Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function

R. P. Raghavan; D. W. Laight; M. H. Cummings

doi:10.1111/ijcp.12310

Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function

International Journal of Clinical Practice ◽

10.1111/ijcp.12310 ◽

2013 ◽

Vol 68 (2) ◽

pp. 271-277 ◽

Cited By ~ 16

Author(s):

R. P. Raghavan ◽

D. W. Laight ◽

M. H. Cummings

Keyword(s):

Oxidative Stress ◽

Insulin Resistance ◽

Type 2 Diabetes ◽

Endothelial Function ◽

Controlled Study ◽

Randomised Controlled Study ◽

Randomised Controlled ◽

Different Doses

Download Full-text

The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2020.07.002 ◽

2020 ◽

Vol 39 ◽

pp. 46-52

Author(s):

Mads N. Thomsen ◽

Mads J. Skytte ◽

Arne Astrup ◽

Carolyn F. Deacon ◽

Jens J. Holst ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

High Protein Diet ◽

Controlled Study ◽

Clinical Effects ◽

Glycaemic Variability ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v1/review5 ◽

2019 ◽

Author(s):

Christine Mermier

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v2/review2 ◽

2019 ◽

Author(s):

Christine Mermier

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70088-x ◽

2007 ◽

Vol 2007 ◽

pp. 150-154

Author(s):

D.H. Bessesen

Keyword(s):

Type 2 Diabetes ◽

Controlled Study ◽

Obese Patients ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/j.yobg.2011.05.175 ◽

2011 ◽

Vol 2011 ◽

pp. 15-16

Author(s):

J.S. Dungan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Low Dose ◽

Controlled Study ◽

Double Blind ◽

Randomised Controlled Study ◽

Dose Combination ◽

Randomised Controlled

Download Full-text

Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay®) on glycaemic control in type 1 and type 2 diabetes patients

Diabetes & Metabolism ◽

10.1016/j.diabet.2009.02.006 ◽

2009 ◽

Vol 35 (4) ◽

pp. 312-318 ◽

Cited By ~ 25

Author(s):

E. Cosson ◽

E. Hamo-Tchatchouang ◽

L. Dufaitre-Patouraux ◽

J.-R. Attali ◽

J. Pariès ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Glucose Monitoring ◽

Controlled Study ◽

Randomised Controlled Study ◽

Randomised Controlled ◽

The Impact ◽

Diabetes Patients

Download Full-text

Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2021-002787 ◽

2021 ◽

pp. ejhpharm-2021-002787

Author(s):

Clement Delage ◽

Hélène Lelong ◽

Francoise Brion ◽

Jacques Blacher

Keyword(s):

Type 2 Diabetes ◽

Clinical Outcomes ◽

Educational Intervention ◽

Controlled Study ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v2/review3 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v1/review2 ◽

2019 ◽

Author(s):

Zhengxiang Huang

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Randomised Controlled Study ◽

Randomised Controlled

Download Full-text